Research Paper Volume 15, Issue 23 pp 14242—14262
Two lncRNA signatures with cuproptosis as a novel prognostic model and clinicopathological value for endometrioid endometrial adenocarcinoma
Figure 3. Clinicopathological analysis and prognostic nomogram based on cuproptosis-related lncRNAs signature. (A–D) Correlation between risk score and molecular subtypes (A), cancer status (B), age (C), and lymph node metastasis (D). (E) Correlation between risk score and survival probability in patients at stage I–II. (F, G) Univariate and multivariate Cox regression analysis. (H) Nomogram for predicting probabilities of EEA patient 1-, 3-, 5-year OS in the TCGA cohort. (I) ROC curves showing the predictive efficiency of the nomogram. (J) Calibration plots of 1-, 3-, and 5-year OS predicted by the nomograms.